Cargando…
Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma
In this study, we investigated the association between PD‐L1 expression in tumor cells and underlying genetic mutations, which was analyzed in detail using laser microdissection and next‐generation sequencing analysis. To investigate whether driver mutations are involved in the background of PD‐L1 e...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396783/ https://www.ncbi.nlm.nih.gov/pubmed/37442887 http://dx.doi.org/10.1111/1759-7714.15038 |
_version_ | 1785083839553470464 |
---|---|
author | Kunimasa, Kei Hirotsu, Yosuke Amemiya, Kenji Honma, Keiichiro Nakamura, Harumi Nishino, Kazumi Omata, Masao |
author_facet | Kunimasa, Kei Hirotsu, Yosuke Amemiya, Kenji Honma, Keiichiro Nakamura, Harumi Nishino, Kazumi Omata, Masao |
author_sort | Kunimasa, Kei |
collection | PubMed |
description | In this study, we investigated the association between PD‐L1 expression in tumor cells and underlying genetic mutations, which was analyzed in detail using laser microdissection and next‐generation sequencing analysis. To investigate whether driver mutations are involved in the background of PD‐L1 expression, the EGFR major activating mutation was selected as the most frequent driver mutation. Surgical resection specimens were used to extract sufficient amounts of nucleic acids for analysis, and the high tumor proportion score (TPS:100%) and low (TPS: 0%) PD‐L1‐expressing parts of the tumor were each laser microdissected to examine the association between PD‐L1 expression heterogeneity and genetic mutations within the same tumor. The association between PD‐L1 heterogeneity and gene mutations within the same tumor was investigated. Analysis showed no association between PD‐L1 expression heterogeneity and genetic variants, which were found to be almost identical. However, PD‐L1 expression was found to be associated with the number of tumor infiltrating lymphocytes (TILs) present in the tumor, which may be related to whether or not lymphocytes can infiltrate into the tumor depending on the tumor histological type (solid pattern, lepidic pattern, etc.) and other factors. |
format | Online Article Text |
id | pubmed-10396783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-103967832023-08-04 Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma Kunimasa, Kei Hirotsu, Yosuke Amemiya, Kenji Honma, Keiichiro Nakamura, Harumi Nishino, Kazumi Omata, Masao Thorac Cancer Brief Report In this study, we investigated the association between PD‐L1 expression in tumor cells and underlying genetic mutations, which was analyzed in detail using laser microdissection and next‐generation sequencing analysis. To investigate whether driver mutations are involved in the background of PD‐L1 expression, the EGFR major activating mutation was selected as the most frequent driver mutation. Surgical resection specimens were used to extract sufficient amounts of nucleic acids for analysis, and the high tumor proportion score (TPS:100%) and low (TPS: 0%) PD‐L1‐expressing parts of the tumor were each laser microdissected to examine the association between PD‐L1 expression heterogeneity and genetic mutations within the same tumor. The association between PD‐L1 heterogeneity and gene mutations within the same tumor was investigated. Analysis showed no association between PD‐L1 expression heterogeneity and genetic variants, which were found to be almost identical. However, PD‐L1 expression was found to be associated with the number of tumor infiltrating lymphocytes (TILs) present in the tumor, which may be related to whether or not lymphocytes can infiltrate into the tumor depending on the tumor histological type (solid pattern, lepidic pattern, etc.) and other factors. John Wiley & Sons Australia, Ltd 2023-07-13 /pmc/articles/PMC10396783/ /pubmed/37442887 http://dx.doi.org/10.1111/1759-7714.15038 Text en © 2023 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Brief Report Kunimasa, Kei Hirotsu, Yosuke Amemiya, Kenji Honma, Keiichiro Nakamura, Harumi Nishino, Kazumi Omata, Masao Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR ‐mutated lung adenocarcinoma |
title | Genetic dissection of intratumor heterogeneity of PD‐L1 expression in
EGFR
‐mutated lung adenocarcinoma |
title_full | Genetic dissection of intratumor heterogeneity of PD‐L1 expression in
EGFR
‐mutated lung adenocarcinoma |
title_fullStr | Genetic dissection of intratumor heterogeneity of PD‐L1 expression in
EGFR
‐mutated lung adenocarcinoma |
title_full_unstemmed | Genetic dissection of intratumor heterogeneity of PD‐L1 expression in
EGFR
‐mutated lung adenocarcinoma |
title_short | Genetic dissection of intratumor heterogeneity of PD‐L1 expression in
EGFR
‐mutated lung adenocarcinoma |
title_sort | genetic dissection of intratumor heterogeneity of pd‐l1 expression in
egfr
‐mutated lung adenocarcinoma |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396783/ https://www.ncbi.nlm.nih.gov/pubmed/37442887 http://dx.doi.org/10.1111/1759-7714.15038 |
work_keys_str_mv | AT kunimasakei geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma AT hirotsuyosuke geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma AT amemiyakenji geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma AT honmakeiichiro geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma AT nakamuraharumi geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma AT nishinokazumi geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma AT omatamasao geneticdissectionofintratumorheterogeneityofpdl1expressioninegfrmutatedlungadenocarcinoma |